Header

UZH-Logo

Maintenance Infos

Highlights and recent developments in allergic diseases in EAACI journals (2019)


Bousquet, J; Grattan, C E; Akdis, C A; Eigenmann, P A; Hoffmann-Sommergruber, K; Agache, I; Jutel, M (2020). Highlights and recent developments in allergic diseases in EAACI journals (2019). Clinical and Translational Allergy, 10:56.

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2019 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidities, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and meta-analyses have been the highlights of the last year.

Abstract

The European Academy of Allergy and Clinical Immunology (EAACI) owns three journals: Allergy, Pediatric Allergy and Immunology and Clinical and Translational Allergy. One of the major goals of EAACI is to support health promotion in which prevention of allergy and asthma plays a critical role and to disseminate the knowledge of allergy to all stakeholders including the EAACI junior members. There was substantial progress in 2019 in the identification of basic mechanisms of allergic and respiratory disease and the translation of these mechanisms into clinics. Better understanding of molecular and cellular mechanisms, efforts for the development of biomarkers for disease prediction, novel prevention and intervention studies, elucidation of mechanisms of multimorbidities, entrance of new drugs in the clinics as well as recently completed phase three clinical studies and publication of a large number of allergen immunotherapy studies and meta-analyses have been the highlights of the last year.

Statistics

Citations

Altmetrics

Downloads

4 downloads since deposited on 11 Jan 2021
4 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > Swiss Institute of Allergy and Asthma Research
Dewey Decimal Classification:610 Medicine & health
Scopus Subject Areas:Health Sciences > Immunology and Allergy
Life Sciences > Immunology
Health Sciences > Pulmonary and Respiratory Medicine
Language:English
Date:1 December 2020
Deposited On:11 Jan 2021 10:25
Last Modified:01 Feb 2021 16:20
Publisher:BioMed Central
ISSN:2045-7022
OA Status:Gold
Free access at:PubMed ID. An embargo period may apply.
Publisher DOI:https://doi.org/10.1186/s13601-020-00366-3
PubMed ID:33292572

Download

Gold Open Access

Download PDF  'Highlights and recent developments in allergic diseases in EAACI journals (2019)'.
Preview
Content: Published Version
Filetype: PDF
Size: 892kB
View at publisher
Licence: Creative Commons: Attribution 4.0 International (CC BY 4.0)